With bitcoin soaring once again, blockchains are suddenly much more valuable. More than 50 of them are now worth over $1 billion—despite many having few users
Action Construction Equipment has been a key beneficiary of the country's rapid infrastructure buildout
She was her husband's biggest cheerleader for decades and rooted for him from the sidelines. Over one-and-a-half years after the death of ace investor Rakesh Jhunjhunwala, the homemaker has made a reluctant transition
By focusing on custom research for global agriculture companies, PI Industries has carved a niche for itself and grown faster than competition
Vietnam's richest person, Pham Nhat Vuong, is investing over $10 billion to turn his EV maker VinFast into a global brand—while facing major challenges in its US market entry
The Forbes India Rich List special is a flagship issue and it has some fascinating stories of those who have built large enterprises over the course of a few decades and are now reaping the fruits. In this podcast, Manu Balachandran talks about the billionaires on the cover of this special edition and the stories you cannot miss while flipping the pages
As social media's poster boy approaches 40, he's having his Bill Gates moment: Mellowing (a bit), maturing (a bit more) and upending his company with staggering confidence. It's a big bet on the future of daily human life—and his legacy
Sridhar Vembu on the outlook for the Indian SaaS sector, top priorities for Zoho over the few quarters, and why he thinks productivity in software development can increase more than ten-fold in the long term
In the coming years, Sridhar Vembu believes it is inevitable that the country will become the biggest market for the company
Anil Rai Gupta concedes he has big shoes to fill at Havells. After a series of setbacks, the manufacturer of fast-moving electrical goods is now reaping the benefits of its diversified focus on exports and ramping up its in-house production capacity along with investing in R&D
As Alkem Laboratories turns 50 years, Forbes India traces its journey from its humble beginnings as a pharma distribution company to a Rs 11,599 crore pharma major